Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    OptimizeRx Corporation

    NASDAQ: OPRX · Real-Time Price · USD
    13.60
    0.95 (7.51%)
    At close: Jun 27, 2025, 3:59 PM
    13.71
    0.81%
    After-hours: Jun 27, 2025, 05:57 PM EDT

    OptimizeRx Statistics

    Share Statistics

    OptimizeRx has 18.5M shares outstanding. The number of shares has increased by 1.21% in one year.

    Shares Outstanding

    n/a
    		 18.5M

    Shares Change (YoY)

    n/a
    		 1.21%

    Shares Change (QoQ)

    n/a
    		 0.38%

    Owned by Institutions (%)

    n/a
    		 62.05%

    Shares Floating

    n/a
    		 16.75M

    Failed to Deliver (FTD) Shares

    n/a
    		 871

    FTD / Avg. Volume

    n/a
    		 0.3%

    Short Selling Information

    The latest short interest is 1.57M, so 8.49% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.57M

    Short % of Shares Out

    n/a
    		 8.49%

    Short % of Float

    n/a
    		 9%

    Short Ratio (days to cover)

    n/a
    		 3.64

    Valuation Ratios

    The PE ratio is -4.42 and the forward PE ratio is 19.18. OptimizeRx's PEG ratio is -0.65.

    PE Ratio

    n/a
    		 -4.42

    Forward PE

    n/a
    		 19.18

    PS Ratio

    n/a
    		 0.97

    Forward PS

    n/a
    		 2.2

    PB Ratio

    n/a
    		 0.76

    P/FCF Ratio

    n/a
    		 18.61

    PEG Ratio

    n/a
    		 -0.65
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for OptimizeRx.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.28.

    Current Ratio

    n/a
    		 2.89

    Quick Ratio

    n/a
    		 2.89

    Debt / Equity

    n/a
    		 0.28

    Debt / EBITDA

    n/a
    		 -3.73

    Debt / FCF

    n/a
    		 6.95

    Interest Coverage

    n/a
    		 -2.23

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $719,742.19

    Profits Per Employee

    n/a
    		 $-157,109.38

    Employee Count

    n/a
    		 128

    Asset Turnover

    n/a
    		 0.54

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 725K

    Effective Tax Rate

    n/a
    		 -3.74%

    Stock Price Statistics

    The stock price has increased by 36% in the last 52 weeks. The beta is 1.33, so OptimizeRx's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.33

    52-Week Price Change

    n/a
    		 36%

    50-Day Moving Average

    n/a
    		 11.52

    200-Day Moving Average

    n/a
    		 7.52

    Relative Strength Index (RSI)

    n/a
    		 56.8

    Average Volume (20 Days)

    n/a
    		 292,301

    Income Statement

    In the last 12 months, OptimizeRx had revenue of 92.13M and earned -20.11M in profits. Earnings per share was -1.1.

    Revenue

    n/a
    		 92.13M

    Gross Profit

    n/a
    		 59.38M

    Operating Income

    n/a
    		 -13.71M

    Net Income

    n/a
    		 -20.11M

    EBITDA

    n/a
    		 -8.9M

    EBIT

    n/a
    		 -13.22M

    Earnings Per Share (EPS)

    n/a
    		 -1.1
    Full Income Statement

    Balance Sheet

    The company has 13.38M in cash and 33.19M in debt, giving a net cash position of -19.81M.

    Cash & Cash Equivalents

    n/a
    		 13.38M

    Total Debt

    n/a
    		 33.19M

    Net Cash

    n/a
    		 -19.81M

    Retained Earnings

    n/a
    		 -84.37M

    Total Assets

    n/a
    		 167.77M

    Working Capital

    n/a
    		 33.36M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 4.89M and capital expenditures -112K, giving a free cash flow of 4.78M.

    Operating Cash Flow

    n/a
    		 4.89M

    Capital Expenditures

    n/a
    		 -112K

    Free Cash Flow

    n/a
    		 4.78M

    FCF Per Share

    n/a
    		 0.26
    Full Cash Flow Statement

    Margins

    Gross margin is 64.45%, with operating and profit margins of -14.88% and -21.83%.

    Gross Margin

    n/a
    		 64.45%

    Operating Margin

    n/a
    		 -14.88%

    Pretax Margin

    n/a
    		 -21.04%

    Profit Margin

    n/a
    		 -21.83%

    EBITDA Margin

    n/a
    		 -9.66%

    EBIT Margin

    n/a
    		 -14.88%

    FCF Margin

    n/a
    		 5.19%

    Dividends & Yields

    OPRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for OPRX is $12, which is -11.8% lower than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $12

    Price Target Difference

    n/a
    		 -11.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 14, 2018. It was a backward split with a ratio of 1:3.

    Last Split Date

    n/a
    		 May 14, 2018

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:3

    Scores

    Altman Z-Score

    n/a
    		 2.47

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist